NCT02289898 2020-09-28
YOSEMITE
Mereo BioPharma
Phase 2 Completed
Clinical Trials
3 trialsNCT01189929 2020-09-09
A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer
Mereo BioPharma
Phase 1 Completed
NCT01189942 2020-09-09
A Study of FOLFIRI Plus OMP-21M18 as 1st or 2nd-line Treatment in Subjects With Metastatic Colorectal Cancer
Mereo BioPharma
Phase 1 Completed